MLAB EBITDA Growth
Mesa Laboratories Inc · EBITDA Growth
MLAB EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-9.16%period ending
MLAB TTM EBITDA YoY % (-400.00% → -9.16%)
Year-over-year change
High-resolution chart · PNG
MLAB ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -9.155% | |
| 4.0087% | |
| 121.0672% | |
| 118.5333% | |
| 119.0538% | |
| 117.4971% | |
| -706.0031% | |
| -707.3297% | |
| -648.7896% | |
| -723.9419% | |
| 0.8001% | |
| 16.1961% | |
| 44.9947% | |
| 17.24% | |
| 14.0844% | |
| 11.3675% | |
| 4.2059% | |
| 16.4362% | |
| 45.7297% | |
| 30.6775% | |
| 34.5742% | |
| 25.1543% | |
| 9.529% | |
| -10.4351% | |
| -13.7431% | |
| -5.3941% | |
| -20.974% | |
| -15.2603% | |
| -14.343% | |
| -7.2076% | |
| 12.7173% | |
| 21.4348% | |
| 15.7419% | |
| 1.6886% | |
| -6.2303% | |
| -0.7989% | |
| 6.3604% | |
| 6.6094% | |
| 18.7541% | |
| 16.6117% | |
| 3.7929% | |
| 9.1868% | |
| 4.7726% | |
| 9.5405% | |
| 37.4514% | |
| 37.6928% | |
| 31.3425% | |
| 26.8539% | |
| 0.559% | |
| 1.067% | |
| 1.9755% | |
| 0.2529% | |
| 11.0812% | |
| 6.5895% | |
| 7.9566% | |
| 11.9681% | |
| 17.7144% | |
| 23.9047% | |
| 40.368% | |
| 40.0438% | |
| 36.9674% | |
| 43.5278% | |
| 22.0119% | |
| 15.0162% | |
| 6.1526% | |
| -2.8231% | |
| 0.5859% | |
| 4.2417% | |
| 8.2726% | |
| 7.6006% | |
| 6.638% | |
| 10.2193% | |
| 16.4359% | |
| 23.2933% | |
| 37.1719% | |
| 42.316% | |
| 42.6115% | |
| 50.5591% | |
| 45.8974% | |
| 35.5774% | |
| 38.2448% | |
| 17.9293% | |
| 7.0578% | |
| 7.3696% | |
| -2.5221% | |
| 6.5132% | |
| 10.5302% | |
| 6.7146% | |
| 1.2518% | |
| 2.2875% | |
| 5.3102% | |
| 8.2562% | |
| 14.3674% | |
| 8.6122% | |
| -17.8321% | |
| -19.4703% | |
| -18.0594% | |
| -22.6972% | |
| 0.8137% | |
| -2.1117% |